S 
Sartorius Stedim Biotech DIM.PA · EUR
Health Care · Life Sciences Tools & Services · Euronext Paris · 🇫🇷 France
226.20
+0.18%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in EUR, from our data supplier.
Revenue
€2.97bn
FY2016FY2025
Net income
€265.6m
FY2016FY2025
Free cash flow
€145.4m
FY2016FY2025
Shareholders' equity
€4.09bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €2.97bn | €2.78bn | €2.78bn | €3.49bn | €2.89bn | €1.91bn | €1.44bn | €1.21bn | €1.08bn | €1.05bn |
| Gross profit | €1.35bn | €1.21bn | €1.23bn | €1.82bn | €1.55bn | €1.00bn | €748.3m | €629.6m | €554.8m | €526.8m |
| Research and development | €132.6m | €144.1m | €129.5m | €132.4m | €110.5m | €84.5m | €79.2m | €60.6m | €53.2m | €47.5m |
| Operating income | €549.0m | €370.6m | €484.5m | €1.11bn | €912.7m | €471.8m | €332.0m | €300.2m | €221.7m | €225.9m |
| Net income | €265.6m | €175.1m | €309.7m | €876.1m | €414.4m | €335.9m | €234.6m | €208.1m | €161.1m | €153.7m |
| Diluted earnings per share | 2.73 | 1.81 | 3.36 | 9.51 | 4.49 | 3.64 | 2.53 | 2.27 | 1.73 | 1.65 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | €8.02bn | €8.26bn | €7.74bn | €5.07bn | €3.95bn | €3.07bn | €1.82bn | €1.57bn | €1.40bn | €1.20bn |
| Cash and short-term investments | €434.2m | €688.8m | €126.1m | €133.0m | €237.3m | €69.6m | €45.9m | €43.2m | €45.4m | €43.0m |
| Total liabilities | €3.89bn | €4.23bn | €5.07bn | €2.55bn | €2.22bn | €1.59bn | €642.8m | €526.6m | €524.5m | €432.3m |
| Debt | €2.60bn | €2.87bn | €3.68bn | €1.14bn | €625.5m | €587.1m | €138.6m | €149.6m | €159.7m | €102.3m |
| Shareholders' equity | €4.09bn | €3.99bn | €2.64bn | €2.45bn | €1.66bn | €1.46bn | €1.16bn | €1.04bn | €872.0m | €758.0m |
| Shares outstanding | 97m | 97m | 92m | 92m | 92m | 92m | 93m | 91m | 93m | 93m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | €538.6m | €815.1m | €746.4m | €612.3m | €696.0m | €416.9m | €310.1m | €227.3m | €174.7m | €156.7m |
| Capital spending | −€393.2m | −€339.8m | −€473.6m | −€430.6m | −€324.0m | −€159.2m | −€136.0m | −€176.5m | −€126.8m | −€79.7m |
| Free cash flow | €145.4m | €475.3m | €272.8m | €181.7m | €372.0m | €257.7m | €174.2m | €50.7m | €47.9m | €76.9m |
| Dividends paid | −€67.1m | −€67.1m | −€132.7m | −€116.1m | −€62.7m | −€31.3m | −€52.5m | −€42.4m | −€38.7m | −€30.7m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | €765.7m | €761.5m | €772.2m | €705.7m | €745.0m | €744.6m | €751.3m | €655.4m |
| Gross profit | €358.8m | €345.4m | €316.9m | €327.4m | €344.7m | €356.3m | €316.3m | €275.4m |
| Operating income | €160.2m | €143.6m | €115.0m | €139.7m | €123.5m | €141.3m | €52.1m | €82.4m |
| Net income | €93.0m | €88.1m | €47.3m | €64.2m | €68.5m | €85.6m | €45.6m | €25.5m |
| Diluted earnings per share | 0.96 | 0.91 | 0.49 | 0.66 | 0.70 | 0.88 | 0.47 | 0.26 |
| Cash from operations | €129.0m | €182.0m | €242.0m | €60.0m | €124.0m | €119.0m | €284.0m | €258.0m |
| Capital spending | −€72.0m | −€69.0m | −€117.0m | −€134.0m | −€75.0m | −€65.0m | −€80.0m | −€70.0m |
| Free cash flow | €57.0m | €113.0m | €125.0m | −€74.0m | €49.0m | €54.0m | €204.0m | €188.0m |
| Total assets | €7.92bn | €8.19bn | €8.02bn | €7.88bn | €8.31bn | €8.30bn | €8.26bn | €8.00bn |
| Cash and short-term investments | €203.9m | €521.2m | €426.1m | €298.7m | €745.1m | €707.6m | €688.8m | €500.8m |
| Debt | €2.26bn | €2.47bn | €2.47bn | €549.5m | €2.82bn | €2.77bn | €2.75bn | €2.72bn |
| Shareholders' equity | €4.24bn | €4.11bn | €4.09bn | €4.04bn | €4.00bn | €3.97bn | €3.99bn | €3.90bn |
Financial ratios
Data as of 29 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 45.3% | 43.4% | 44.4% | 52.0% | 53.8% | 52.5% |
| Operating margin | 18.5% | 13.3% | 17.5% | 31.8% | 31.6% | 24.7% |
| Net margin | 9.0% | 6.3% | 11.2% | 25.1% | 14.4% | 17.6% |
| Return on equity | 6.5% | 4.4% | 11.7% | 35.8% | 25.0% | 23.0% |
| Return on assets | 3.3% | 2.1% | 4.0% | 17.3% | 10.5% | 10.9% |
| Free cash flow yield | 4.3% | 5.4% | 6.0% | 5.1% | 5.0% | 2.8% |
| Revenue growth | 6.7% | 0.2% | -20.5% | 21.0% | 51.1% | 32.6% |
| Earnings growth | 51.7% | -43.5% | -64.7% | 111.4% | 23.4% | 43.2% |
| Current ratio | 1.02x | 1.85x | 1.51x | 1.61x | 1.40x | 1.54x |
| Debt to equity | 0.60x | 0.69x | 1.36x | 0.43x | 0.34x | 0.37x |
| Equity ratio | 51.0% | 48.3% | 34.1% | 48.4% | 41.9% | 47.6% |
| Interest coverage | 3.60x | 2.33x | 4.00x | 27.09x | 38.54x | 12.51x |
| R&D as a share of sales | 4.5% | 5.2% | 4.7% | 3.8% | 3.8% | 4.4% |
| Buybacks as a share of market value | -0.5% | -5.0% | 0.0% | 0.2% | -0.1% | 0.7% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -5.3% | 9.2% | 12.9% |
| Operating income | -20.9% | 3.1% | 11.5% |
| Net income | -32.8% | -4.6% | 8.5% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 44.4% | 46.6% | 48.5% | 49.2% |
| Operating margin | 16.0% | 20.9% | 23.2% | 23.0% |
| Net margin | 7.7% | 13.5% | 14.1% | 14.5% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 76.3 | 104.3 | 71.3 | 31.8 | 107.5 | 79.9 | 58.5 | 38.4 | 34.9 | 36.4 |
| Price to sales | 6.8 | 6.6 | 8.0 | 8.0 | 15.4 | 14.1 | 9.5 | 6.6 | 5.2 | 5.3 |
Dividends and splits
Per share, in the currency the company pays
Paid for 26 years. Last went ex-dividend on 31 Mar 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.69 | 0.69 | 0.69 | 1.44 | 2.52 | 0.68 | 0.34 | 0.57 |
- 6-for-1 split · 6 May 2016
- 5-for-1 split · 16 Jun 2005
- 11-for-10 split · 13 Jul 2004
- 11-for-10 split · 15 Jul 2003
- 11-for-10 split · 12 Jul 2002
- 11-for-10 split · 11 Jul 2001
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.